Clinical Trial Update: Precision-Based Genomics in Prostate Cancer

View source ↗

Summary

A National Cancer Institute-sponsored clinical trial exploring precision-based genomic approaches in prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer | Status: RECRUITING